Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Johnson & Johnson (NYSE: JNJ) has announced an investor conference call to review its third-quarter results on Tuesday, October 15th at 8:30 a.m. Eastern Time. The call will be hosted by Joaquin Duato (Chairman and CEO), Joseph J. Wolk (EVP and CFO), and Jessica Moore (VP of Investor Relations). Additional executive team members will participate in the Q&A session.
Investors can access the webcast and presentation materials at www.investor.jnj.com. The U.S. dial-in number is 877-869-3847, while international participants can call 201-689-8261. A replay will be available until October 29th. The press release will be available at approximately 6:45 a.m. ET on the day of the call.
Johnson & Johnson (NYSE: JNJ) ha annunciato una conferenza telefonica per gli investitori per rivedere i risultati del terzo trimestre il martedì 15 ottobre alle 8:30 a.m. ora orientale. La chiamata sarà condotta da Joaquin Duato (Presidente e CEO), Joseph J. Wolk (EVP e CFO) e Jessica Moore (VP delle Relazioni con gli Investitori). Altri membri del team esecutivo parteciperanno alla sessione di domande e risposte.
Gli investitori possono accedere al webcast e ai materiali di presentazione su www.investor.jnj.com. Il numero per gli Stati Uniti è 877-869-3847, mentre i partecipanti internazionali possono chiamare il 201-689-8261. Una registrazione sarà disponibile fino al 29 ottobre. Il comunicato stampa sarà disponibile intorno alle 6:45 a.m. ET il giorno della chiamata.
Johnson & Johnson (NYSE: JNJ) ha anunciado una conferencia telefónica para inversores para revisar sus resultados del tercer trimestre el martes 15 de octubre a las 8:30 a.m. hora del Este. La llamada será dirigida por Joaquin Duato (Presidente y CEO), Joseph J. Wolk (EVP y CFO) y Jessica Moore (VP de Relaciones con Inversores). Otros miembros del equipo ejecutivo participarán en la sesión de preguntas y respuestas.
Los inversores pueden acceder al webcast y a los materiales de presentación en www.investor.jnj.com. El número para EE. UU. es 877-869-3847, mientras que los participantes internacionales pueden llamar al 201-689-8261. Una grabación estará disponible hasta el 29 de octubre. El comunicado de prensa estará disponible aproximadamente a las 6:45 a.m. ET el día de la llamada.
존슨 & 존슨 (NYSE: JNJ)은 10월 15일 화요일 오전 8시 30분 동부 표준시에 3분기 실적 검토를 위한 투자자 전화 회의를 발표했습니다. 이 통화는 호아킨 두아토 (회장 겸 CEO), 조셉 J. 월크 (EVP 겸 CFO) 및 제시카 무어 (투자자 관계 담당 부사장)가 주관합니다. 추가로 여러 임원들이 질의응답 세션에 참여할 것입니다.
투자자들은 www.investor.jnj.com에서 웹캐스트 및 발표 자료에 접근할 수 있습니다. 미국 전화번호는 877-869-3847이며, 국제 참가자는 201-689-8261로 전화를 걸 수 있습니다. 통화 후 재생은 10월 29일까지 가능합니다. 보도자료는 통화 당일 오전 6시 45분 ET경에 제공될 예정입니다.
Johnson & Johnson (NYSE: JNJ) a annoncé une conférence téléphonique pour investisseurs afin d'examiner ses résultats du troisième trimestre le mardi 15 octobre à 8h30, heure de l'Est. L'appel sera animé par Joaquin Duato (Président et PDG), Joseph J. Wolk (EVP et CFO) et Jessica Moore (VP des relations avec les investisseurs). D'autres membres de l'équipe dirigeante participeront à la session de questions-réponses.
Les investisseurs peuvent accéder au webcast et aux documents de présentation sur www.investor.jnj.com. Le numéro de téléphone aux États-Unis est le 877-869-3847, tandis que les participants internationaux peuvent composer le 201-689-8261. Un enregistrement sera disponible jusqu'au 29 octobre. Le communiqué de presse sera publié aux alentours de 6h45 ET le jour de l'appel.
Johnson & Johnson (NYSE: JNJ) hat eine Investorenkonferenzschaltung angekündigt, um die Ergebnisse des dritten Quartals am Dienstag, den 15. Oktober um 8:30 Uhr Eastern Time zu überprüfen. Die Konferenz wird von Joaquin Duato (Vorsitzender und CEO), Joseph J. Wolk (EVP und CFO) sowie Jessica Moore (VP für Investor Relations) moderiert. Weitere Mitglieder des Führungsteams werden an der Q&A-Sitzung teilnehmen.
Investoren können auf das Webcast und die Präsentationsmaterialien unter www.investor.jnj.com zugreifen. Die US-Teilnehmernummer ist 877-869-3847, während internationale Teilnehmer die 201-689-8261 wählen können. Eine Aufnahme der Sitzung wird bis zum 29. Oktober verfügbar sein. Die Pressemitteilung wird am Tag des Anrufs etwa um 6:45 Uhr ET bereitgestellt.
- None.
- None.
Investors and other interested parties can access the webcast/conference call in the following ways:
- The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
-
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the
U.S. is 877-869-3847. For participants outside theU.S. , the dial-in number is 201-689-8261. -
A replay of the conference call will be available until approximately 12:00 a.m. on October 29th. The replay dial-in number for
U.S. participants is 877-660-6853. For participants outside theU.S. , the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13748405. - The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
- Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the fourth-quarter date of Wednesday, January 22nd, 2025.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905080615/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When is Johnson & Johnson (JNJ) hosting its Q3 2023 earnings call?
Who will be presenting during Johnson & Johnson's (JNJ) Q3 2023 earnings call?
How can investors access Johnson & Johnson's (JNJ) Q3 2023 earnings call?
When will Johnson & Johnson (JNJ) release its Q3 2023 earnings press release?
